SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Catalyst Pharmaceuticals Q1 EPS $0.100 Beats $0.090 Estimate, Sales $29.100M Miss $31.460M Estimate

Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.100 per share which beat the analyst consensus estimate of $0.090 by 11.11 percent. This is a 1100 percent increase over losses of $(0.010) per

Benzinga · 05/11/2020 20:24

Catalyst Pharmaceuticals (NASDAQ:CPRX) reported quarterly earnings of $0.100 per share which beat the analyst consensus estimate of $0.090 by 11.11 percent. This is a 1100 percent increase over losses of $(0.010) per share from the same period last year. The company reported quarterly sales of $29.100 million which missed the analyst consensus estimate of $31.460 million by 7.50 percent. This is a 133.77 percent increase over sales of $12.448 million the same period last year.